aPTT |
Activated partial thromboplastin time |
BCT |
Blood-component therapy |
CCA |
Conventional coagulation assay |
CFT |
Clot formation time (ROTEM® parameter) |
CRYO |
Cryoprecipitate |
CT |
Clotting time (ROTEM® parameter) |
DCR |
Damage control resuscitation |
ECMO |
Extracorporeal membrane oxygenation |
FFP |
Fresh frozen plasma |
INR |
International normalized ratio |
iTACTIC |
implementing Treatment Algorithms for the Correction of Trauma-Induced Coagulopathy (clinical trial) |
K |
Clot formation time |
LI30 |
Lysis index at 30 min (ROTEM® parameter) |
LY30 |
Lysis at 30 min (TEG® parameter) |
MA |
Maximum amplitude (TEG® parameter) |
MCF |
Maximum clot firmness (ROTEM® parameter) |
ML |
Maximum lysis |
MT |
Massive transfusion |
NATO |
North Atlantic Treaty Organization |
POC |
Point-of-care |
PPOWER |
Pragmatic, Prehospital, Type O, Whole Blood Early Resuscitation (clinical trial) |
PROPPER |
Pragmatic Randomized Optimal Platelet and Plasma Ratios (clinical trial) |
PT |
Prothrombin time |
R |
Reaction time (TEG® parameter) |
RBC |
Red blood cells |
ROTEM®
|
Rotational thromboelastometry®
|
r-TEG®
|
Rapid-thromboelastography®
|
STORHM |
Sang Total dans les Hémorragies Massives (clinical trial) |
SWAT |
Shock Whole blood and Assessment of TBI (clinical trial) |
TEG®
|
Thromboelastography®
|
THOR Network |
Trauma Hemostasis and Oxygenation Research Network |
TIC |
Trauma-induced coagulopathy |
TOWAR |
Type O Whole Blood and Assessment of Age During Prehospital Resuscitation (clinical trial) |
VHA |
Viscoelastic hemostatic assay |
WB |
Whole blood |
α-angle |
Alpha angle |